Strategy, planning and management of CMC, Quality and Regulatory for late-stage program and research projects.

Program management across a range of Clinical, CMC, Regulatory and Discovery teams.

Trusted pharma subject matter expert with expertise in strategic project and program management that spans many functional areas. Skilled at analysis and making connections with people. Recognized for leadership, execution and quality of deliverables.

Head of program management. Time is divided between consulting and internal strategy.Assignments have included PM for rare disease product development team, market research and oncology R&D consulting.

Creative and results-driven Senior Management Professional, recognized for successful project and relationship management. Experienced in roles with both tactical and strategic needs. Proven record facilitating partner communication and interaction. Diverse experience delivering quality enhancements, resulting in operational process improvements and cost savings. Key skills and strengths include: change management, process re-engineering, post-acquisition data integration, relationship building and management, concise and effective communication, strategic program and portfolio management.Project and program manager for 2 multi-billion dollar global acquisition projects for a pharmaceutical client. Consulted across 5 acquisitions. Project manager for data and systems PMO and clinical domain. Scope included planning integration for ongoing global trials. Responsible for all aspects of program delivery (facilitation, documentation, communication, risk and issue mitigation). Established process and tools for integration of data into client systems.Project manager and executive summary author for vendor oversight teams across 70+ clinical trial processes. Coordinated and facilitated review meetings. Summarized monthly for senior leaders. Managed initiative to implement process improvement for safety reporting process. Used data visualization to present problem to stakeholders. Developed and implemented solution. Designed reports to monitor impact on compliance. Project resulted in dramatic improvement in compliance

Example assignments:Relationship building and management.Successfully managed and implemented a strategic sourcing partnership with external contract research organization (CRO). Developed and implemented search strategy to identify and evaluate candidate partners. Used research and personal network to identify candidate CROs, interviewed candidates, performed site visit for high potential candidates, negotiated contracts and presented recommendation.Global Target Opportunity/Analyst.Managed initiative to identify and evaluate technology solutions and opportunities, working with C-level executives and KOLs across the globe; assisted an international firm with understanding business trends and opportunities to enhance its technology base and pipeline.Communication strategy.Developed strategy and implemented improvements in company communications including executive summaries, financial projections, and investor presentations for Healthcare IT firm. Developed tag-line to communicate value proposition. Additional assignments included:Strategic planning.Market analysis.Crowdfunding strategy.Business plan preparation.

Business plan preparation, market analysis, and risk assessments for biotechnology start-up with novel platform technology.

Scientific accomplishments:Pfizer visiting Scientist at The Scripps Research Institute (2008-2009) in the Bartfai lab to identify CNS drug targets and pathways for diabetes therapies. Scripps/Pfizer project yielded novel targets, novel peptides, and 2 manuscripts. Identified strategic partners and co-developed a skeletal muscle collaboration with the McGowan Institute for Regenerative Medicine and Pfizer Cambridge scientists which resulted in validation of a novel human stem cell model for insulin sensitivity. Led secretome analysis team and screening effort to identify neuropeptides involved in glucose homeostasis. Team delivered in vivo translation data for a novel peptide that stimulated insulin and GLP-1 release. Transferred innovative secretome strategy to 2 additional teams. Business accomplishments:Performed financial modeling for Pfizer World Wide Comparative Medicine Operations Team, which provided enterprise wide resource allocation strategy for 2012 for increased transparency, flexibility, and accountability. Metrics based analysis was used to drive the proposal. Directed root cause analysis to identify new solutions for colleague development and presented findings to the global executive team of Pfizer Research and Development for review and approval. The business case was concisely presented and led to coaching and development program implementation. Received Pfizer Achievement Award for creation of professional development programs that provided opportunities for colleagues to learn and practice leadership skills and build business acumen. The programs were used as a model for similar networking groups across the corporation globally. Invited speaker at year-end meetings and business unit town hall events to promote best practices for colleague development initiatives. Led strategic drug discovery operations of 2 teams to deliver timely results with limited resource expenditures.

Accountable for network strategy, identification of co-chair elects for 2008 and mentoring of those positions, interactions with and awareness of the activities of the global and local Diversity and Inclusion councils, facilitation and coordination of the board to drive alignment of board activities to the overall Pfizer business strategy, alignment of strategy and shared efforts with groups at other sites. In 2007, a new charter was developed and adopted and the network grew to record membership and level of engagement.